These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 34015382)
1. Precipitation from amorphous solid dispersions in biorelevant dissolution testing: The polymorphism of regorafenib. Müller M; Platten F; Dulle M; Fischer B; Hoheisel W; Serno P; Egelhaaf S; Breitkreutz J Int J Pharm; 2021 Jun; 603():120716. PubMed ID: 34015382 [TBL] [Abstract][Full Text] [Related]
2. Impact of HPMCAS on the Dissolution Performance of Polyvinyl Alcohol Celecoxib Amorphous Solid Dispersions. Monschke M; Wagner KG Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32545270 [TBL] [Abstract][Full Text] [Related]
3. Impact of co-administered stabilizers on the biopharmaceutical performance of regorafenib amorphous solid dispersions. Müller M; Wiedey R; Hoheisel W; Serno P; Breitkreutz J Eur J Pharm Biopharm; 2021 Dec; 169():189-199. PubMed ID: 34756974 [TBL] [Abstract][Full Text] [Related]
4. Dissolution and precipitation behavior of amorphous solid dispersions. Alonzo DE; Gao Y; Zhou D; Mo H; Zhang GGZ; Taylor LS J Pharm Sci; 2011 Aug; 100(8):3316-3331. PubMed ID: 21607951 [TBL] [Abstract][Full Text] [Related]
5. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels. Sun DD; Ju TC; Lee PI Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548 [TBL] [Abstract][Full Text] [Related]
6. A Simultaneous Differential Scanning Calorimetry-X-ray Diffraction Study of Olanzapine Crystallization from Amorphous Solid Dispersions. Askin S; Gonçalves AD; Zhao M; Williams GR; Gaisford S; Craig DQM Mol Pharm; 2020 Nov; 17(11):4364-4374. PubMed ID: 33074007 [TBL] [Abstract][Full Text] [Related]
7. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution. Purohit HS; Taylor LS Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218 [TBL] [Abstract][Full Text] [Related]
8. Variation in Supersaturation and Phase Behavior of Ezetimibe Amorphous Solid Dispersions upon Dissolution in Different Biorelevant Media. Elkhabaz A; Sarkar S; Dinh JK; Simpson GJ; Taylor LS Mol Pharm; 2018 Jan; 15(1):193-206. PubMed ID: 29161509 [TBL] [Abstract][Full Text] [Related]
9. Insights into the Release Mechanisms of ITZ:HPMCAS Amorphous Solid Dispersions: The Role of Drug-Rich Colloids. Nunes PD; Pinto JF; Henriques J; Paiva AM Mol Pharm; 2022 Jan; 19(1):51-66. PubMed ID: 34919407 [TBL] [Abstract][Full Text] [Related]
10. Dissolution performance of binary amorphous drug combinations--Impact of a second drug on the maximum achievable supersaturation. Trasi NS; Taylor LS Int J Pharm; 2015 Dec; 496(2):282-90. PubMed ID: 26456250 [TBL] [Abstract][Full Text] [Related]
11. Solvent change co-precipitation with hydroxypropyl methylcellulose phthalate to improve dissolution characteristics of a poorly water-soluble drug. Sertsou G; Butler J; Hempenstall J; Rades T J Pharm Pharmacol; 2002 Aug; 54(8):1041-7. PubMed ID: 12195817 [TBL] [Abstract][Full Text] [Related]
12. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF. Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525 [TBL] [Abstract][Full Text] [Related]
13. Effects of tablet formulation and subsequent film coating on the supersaturated dissolution behavior of amorphous solid dispersions. Sakai T; Hirai D; Kimura SI; Iwao Y; Itai S Int J Pharm; 2018 Apr; 540(1-2):171-177. PubMed ID: 29447848 [TBL] [Abstract][Full Text] [Related]
14. Supersaturation of zafirlukast in fasted and fed state intestinal media with and without precipitation inhibitors. Madsen CM; Boyd B; Rades T; Müllertz A Eur J Pharm Sci; 2016 Aug; 91():31-9. PubMed ID: 27260089 [TBL] [Abstract][Full Text] [Related]
15. An Artificial Gut/Absorption Simulator: Understanding the Impact of Absorption on In Vitro Dissolution, Speciation, and Precipitation of Amorphous Solid Dispersions. Jain KMH; Hou HH; Siegel RA Mol Pharm; 2024 Apr; 21(4):1884-1899. PubMed ID: 38512389 [TBL] [Abstract][Full Text] [Related]
16. Effect of drug-polymer interactions on the aqueous solubility of milled solid dispersions. Al-Obaidi H; Lawrence MJ; Shah S; Moghul H; Al-Saden N; Bari F Int J Pharm; 2013 Mar; 446(1-2):100-5. PubMed ID: 23410988 [TBL] [Abstract][Full Text] [Related]
17. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type. Jackson MJ; Kestur US; Hussain MA; Taylor LS Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718 [TBL] [Abstract][Full Text] [Related]
18. Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: A review from bench to clinic. Butreddy A Eur J Pharm Biopharm; 2022 Aug; 177():289-307. PubMed ID: 35872180 [TBL] [Abstract][Full Text] [Related]
19. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone. Caron V; Tajber L; Corrigan OI; Healy AM Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367 [TBL] [Abstract][Full Text] [Related]
20. The Amorphous Quercetin/ Hydroxypropylmethylcellulose Acetate Succinate Solid Dispersions Prepared by Co-Precipitation Method to Enhance Quercetin Dissolution. Wang Y; Fang Y; Zhou F; Liang Q; Deng Y J Pharm Sci; 2021 Sep; 110(9):3230-3237. PubMed ID: 34004218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]